MT-ATP6 and COVID-19: That’s why the study aimed to identify mutations in the MT-CYB and MT-ATP6 genes of mtDNA in COVID-19 patients and healthy individuals, assess the association of identified mutations with disease outcomes, and evaluate the pathogenicity of mutations found in COVID-19 patients compared to healthy controls.